These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2757951)

  • 1. Polymorphonuclear leukocytes in psoriatic smokers.
    Cox N
    Br J Dermatol; 1989 Jul; 121(1):143. PubMed ID: 2757951
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte random migration and chemotaxis in psoriatic and healthy adult smokers and non-smokers.
    Sonnex TS; Carrington P; Norris P; Greaves MW
    Br J Dermatol; 1988 Nov; 119(5):653-9. PubMed ID: 3207619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients.
    Bunse T; Mahrle G
    Acta Derm Venereol; 1996 Jan; 76(1):10-2. PubMed ID: 8721481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphonuclear leukocytes in psoriasis.
    Glinski W; Mansbridge J
    Cutis; 1985 May; 35(5):441-2. PubMed ID: 4006509
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development and a clinical test of a method of assessing the interactions between polymorphonuclear leukocytes and monocytes in human blood].
    Adamenko GP
    Lab Delo; 1991; (9):51-4. PubMed ID: 1721959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and comparison of phagocytic function and viability of polymorphonuclear leukocytes in saliva of smokers and non-smokers.
    Archana MS; Bagewadi A; Keluskar V
    Arch Oral Biol; 2015 Feb; 60(2):229-33. PubMed ID: 25463900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathologic mechanisms in the development of psoriatic lesions].
    Mutevelić-Arslanagić N
    Lijec Vjesn; 1992; 114(9-12):296-300. PubMed ID: 1343137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis--measurement of lucigenin-dependent chemiluminescence.
    Kapp A; Schöpf E
    Acta Derm Venereol; 1986; 66(4):285-9. PubMed ID: 2430396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis.
    Lazarus GS; Yost FJ; Thomas CA
    Science; 1977 Dec; 198(4322):1162-3. PubMed ID: 929193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoembryonic antigen and neutrophils in healthy smokers].
    Kashiwabara K; Nakamura H; Kiguchi T; Yagyu H; Kishi K; Matsuoka K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):154-9. PubMed ID: 9103851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophils.
    Majewski S; Jabłonska S; Langner A; Pawinska M; Szmurło A
    Br J Dermatol; 1985 Jun; 112(6):655-62. PubMed ID: 4038367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
    van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
    Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased leukotriene B4 synthesis in polymorphonuclear leukocytes of smokers.
    Schlosser K; Ulmer WT
    Klin Wochenschr; 1988; 66 Suppl 11():120-4. PubMed ID: 2846951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased neutrophil adherence in psoriasis: role of the human endothelial cell receptor Thy-1 (CD90).
    Wetzel A; Wetzig T; Haustein UF; Sticherling M; Anderegg U; Simon JC; Saalbach A
    J Invest Dermatol; 2006 Feb; 126(2):441-52. PubMed ID: 16374458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of psoriatic patients' neutrophils and sera on angiogenic capability and natural cytotoxicity of normal human peripheral blood mononuclear cells.
    Majewski S; Wasik M; Jabłońska S; Tigałonowa M; Langner A
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):465-70. PubMed ID: 2484151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. An important clue.
    Lazarus GS; Gilgor RS
    Arch Dermatol; 1979 Oct; 115(10):1183-4. PubMed ID: 507858
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous peritoneal dialysis for treatment of psoriasis. I. Depletion of PMNL as a possible factor for clearing of psoriatic lesions.
    Gliński W; Jabłońska S; Imiela J; Nosarzewski J; Jarzabek-Chorzelska M; Haftek M; Obałek S
    Arch Dermatol Res; 1979 Jul; 265(3):337-41. PubMed ID: 475457
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.